Everolimus trIal for Advanced prememopausaL Breast Cancer Patients
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Everolimus|DRUG: Goserelin|DRUG: Letrozole
Sponsor: Chinese Academy of Medical Sciences
Collaborators: Novartis Pharmaceuticals